Clinical Trial Update: Tumor RNA Transfected Dendritic Cell Vaccines [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of tumor RNA-transfected dendritic cell vaccines for prostate cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Tumor RNA Transfected Dendritic Cell Vaccine

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED